甲基胺通过 ангиотензин II 和中间导电性激活通道诱导内皮功能障碍
Xuehui Fan1, Guoqiang Yang2, Zhen Yang3
1Department of Cardiology, Angiology, Hemostaseology and Medical Intensive Care, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), Heidelberg University, Mannheim, Germany; Key Laboratory of Medical Electrophysiology of the Ministry of Education, Medical Electrophysiological Key Laboratory of Sichuan Province, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China; European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) partner site Heidelberg/Mannheim, Mannheim, Germany; Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
在Takotsubo综合征中,高含量的甲醇胺因增加血管素II (Ang II) 而导致内皮功能障碍. 安格II通过ROS和PKA抑制SK4通道,损害细胞功能.
科学领域:
- 心血管生物学 心血管生物学
- 内皮细胞功能 内皮细胞功能
- 分子机制的分子机制
背景情况:
- 内皮功能障碍与塔科苏博综合征 (TTS) 病变发生有关.
- 在TTS中内皮功能障碍的确切机制尚不清楚.
- 过多的catecholamine是TTS的标志,但它对内皮细胞的直接影响需要进一步阐明.
研究的目的:
- 研究血管素II (Ang II) 和Ca2+激活的K+ (SK4) 介导通道在catecholamine诱导的内皮功能障碍中的作用.
- 在TTS模型中阐明连接catecholamines与内皮细胞功能障碍的信号通路.
- 确定Ang II如何影响SK4通道活动和细胞功能.
主要方法:
- 人类心脏微血管内皮细胞 (HCMEC) 用上腺素 (Epi) 治疗,以模仿TTS条件.
- 检测包括测量内甲蛋白-1 (ET-1),氧化 (NO),细胞亡和管道形成.
- 进行了电生理学,反应性氧物种 (ROS) 检测和蛋白质表达分析 (例如,PKA).
主要成果:
- 上腺素增加了ET-1并降低了HCMEC中的NO水平,这些影响被Ang II受体阻塞剂减轻.
- 安格II模仿了上腺素的作用,抑制了管形成,并增加了亡.
- 安格II通过增加ROS和减少PKA来抑制SK4通道电流,导致内皮功能障碍. 上腺素通过α1受体/Gq/PKC通路刺激Ang II的释放.
结论:
- 如在TTS中所见,高水平的甲基荷胺促进内皮细胞释放Ang II.
- 由ROS和降低的PKA驱动的SK4通道的Ang II介导的抑制,显著地促进了catecholamine诱导的内皮功能障碍.
- 针对Ang II/SK4通道轴可能为TTS提供治疗策略.
更多相关视频
09:08Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies
Published on: May 24, 2021
07:19Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique
Published on: February 7, 2025
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
